Ciglitazone induces early cellular proliferation and NF-κB transcriptional activity in colon cancer cells through p65 phosphorylation

International Journal of Biochemistry and Cell Biology

Volumn 37, Issue 3, 2005, Pages 645-654

  Chen, Fei ^a   Harrison, Lawrence E ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Colon cancer; NF B; Phosphorylation; PPAR

Indexed keywords

CIGLITAZONE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; SYNAPTOTAGMIN; WORTMANNIN;

ARTICLE; CANCER CELL; CELL PROLIFERATION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DNA BINDING; DRUG MECHANISM; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION;

BETA-GALACTOSIDASE; BLOTTING, WESTERN; CACO-2 CELLS; CELL NUCLEUS; CELL PROLIFERATION; CYTOPLASM; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HT29 CELLS; HUMANS; LUCIFERASES; NF-KAPPA B; PHOSPHORYLATION; PPAR GAMMA; PRECIPITIN TESTS; THIAZOLIDINEDIONES; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 11144262773     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2004.08.008     Document Type: Article

References (30)

1. S.J. Baek, L.C. Wilson, L.C. His, and T.E. Eling Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity J. Biol. Chem. 278 2003 5845 5853
2. M. Barkett, and T.D. Gilmore Control of apoptosis by Rel/NF-κB transcription factors Oncogene 18 1999 6910 6924
3. H.S. Camp, S.R. Tafuri, and T. Leff c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma1 and negatively regulates its transcriptional activity Endocrinology 140 1999 392 397
4. L.F. Chen, and W.C. Greene Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation J. Mol. Med. 81 2003 549 575
5. F. Chen, and G.P. Studzinski Cyclin-dependent kinase 5 activity enhances monocytic phenotype and cell cycle traverse in 1, 25-dihydroxyvitamin D3-treated HL60 cells Exp. Cell Res. 249 1999 422 428
6. F. Chen, M. Wang, J.P. O'Connor, M. He, T. Tripathi, and L.E. Harrison Phosphorylation of PPARgamma via active ERK1/2 leads to its physical association with p65 and inhibition of NF-kappabeta J. Cell Biochem. 80 2003 732 744
7. G. Chinetti, S. Griglio, M. Antonucci, I.P. Torra, P. Delerive, and Z. Majd Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages J. Biol. Chem. 273 1998 25573 25580
8. C.E. Clay, A. Monjazeb, J. Thorburn, F.H. Chilton, and K.P. High 15-Deoxy-delta12, 14-prostaglandin J2-induced apoptosis does not require PPARgamma in breast cancer cells Lipid Res. 43 2002 1818 1828
9. S.A. Coolican, D.S. Samuel, D.Z. Ewton, F.J. McWade, and J.R. Florini The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways J. Biol. Chem. 272 1997 6653 6662
10. R.N. DuBois, R. Gupta, J. Brockman, B.S. Reddy, S.L. Krakow, and M.A. Lazar The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers Carcinogenesis 19 1998 49 53
11. R. Feinman, K.O. Clarke, and L.E. Harrison Phenylbutyrate-induced apoptosis is associated with inactivation of NF-κB IN HT-29 colon cancer cells Cancer Chemother. Pharmacol. 49 2002 27 34
12. L.C. Hsi, L. Wilson, J. Nixon, and T.E. Eling 15-Lipoxygenase-1 metabolites down-regulate peroxisome proliferator-activated receptor gamma via the MAPK signaling pathway J. Biol. Chem. 276 2001 34545 43552
13. C. Jobin, and R.B. Sartor The I kappa B/NF-kappa B system: A key determinant of mucosalinflammation and protection Am. J. Physiol. Cell Physiol. 278 2000 C451 C462
14. S. Kersten, B. Desvergne, and W. Wahli Roles of PPARs in health and disease Nature 405 2000 421 424
15. S.A. Kliewer, and T.M. Willson The nuclear receptor PPARgamma: Bigger than fat Curr. Opin. Genet. Dev. 8 2000 576 581
16. A.M. Lefebvre, I. Chen, P. Desreumaux, J. Najib, J.C. Fruchart, and K. Geboes Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice Nat. Med. 4 1998 1053 1057
17. A.M. Lennon, M. Ramauge, A. Dessouroux, and M. Pierre MAP kinase cascades are activated in astrocytes and preadipocytes by 15-deoxy-delta(12-14)- prostaglandin J(2) and the thiazolidinedione ciglitazone through peroxisome proliferator activator receptor gamma-independent mechanisms involving reactive oxygenated species J. Biol. Chem. 277 2002 29681 29685
18. L.V. Madrid, M.W. Mayo, J.Y. Reuther, and A.S. Baldwin Jr. Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-B through utilization of the IB kinase and activation of the mitogen-activated protein kinase p38 J. Biol. Chem. 276 2001 18934 18940
19. M.W. Mayo, and A.S. Baldwin The transcription factor NF-κB: Control of oncogenesis and cancer therapy resistance Biochem. Biophys. Acta 1470 2000 55 62
20. C. Qin, R. Burghardt, R. Smith, M. Wormke, J. Stewart, and S. Safe Peroxisome proliferator-activated receptor gamma agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor alpha in MCF-7 breast cancer cells Cancer Res. 63 2003 958 964
21. E. Saez, P. Tontonoz, M.C. Nelson, J.G. Alvarez, U.T. Ming, and S.M. Baird Activators of the nuclear receptor PPARgamma enhance colon polyp formation Nat. Med. 4 1998 1058 1061
22. H. Sakurai, H. Chiba, H. Miyoshi, T. Sugita, and W. Toriumi IKB kinases phosphorylate NF-B p65 subunit on serine 536 in the transactivation domain J. Biol. Chem. 274 1999 30353 30356
23. P. Sarraf, E. Mueller, D. Jones, F.J. King, D.J. DeAngelo, and J.B. Partridge Differentiation and reversal of malignant changes in colon cancer through PPARgamma Nat. Med. 4 1998 1046 1052
24. N. Sizemore, N. Lerner, N. Dombrowski, H. Sakurai, and G.R. Stark Distinct roles of the Ikappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa B) from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B J. Biol. Chem. 277 2002 3863 3869
25. D.S. Straus, G. Pascual, M. Li, J.S. Welch, M. Ricote, and C.H. Hsiang 15-Deoxy-delta 12, 14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway Proc. Natl. Acad. Sci. U.S.A. 97 2000 4844 4849
26. C.G. Su, X. Wen, S.T. Bailey, W. Jiang, S.M. Rangwala, and S.A. Keilbaugh A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response J. Clin. Invest. 104 1999 383 389
27. K. Takeda, T. Ichiki, T. Tokuou, N. Iino, and A. Takeshita 15-Deoxy-delta 12, 14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells J. Biol. Chem. 276 2001 48950 48955
28. T. Tanaka, H. Kohno, S. Yoshitani, S. Takashima, A. Okumura, and A. Murakami Ligands for peroxisome proliferator-activated receptors alpha and gamma inhibit chemically induced colitis and formation of aberrant crypt foci in rats Cancer Res. 61 2001 2424 2428
29. D. Wang, S.D. Westerheide, J.L. Hanson, and A.S. Baldwin Jr. Tumor necrosis factor-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II J. Biol. Chem. 275 2000 32592 32597
30. H. Zhong, M.J. May, E. Jimi, and S. Ghosh The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1 Mol. Cell. 9 2002 625 636